Sudeep Pharma is all set to finalize its share allotment today, following a three-day subscription period for its ₹895 crore IPO, which ran from November 21 to 25, 2025.
The IPO saw overwhelming demand, with applications for over 99 crore shares—far exceeding the 1.05 crore shares available.
This resulted in an overall subscription of 93.71 times, according to NSE data.
Subscription Details
Retail Investors: 15.65 times subscription
Non-Institutional Investors (NIIs): 116.72 times subscription
Qualified Institutional Buyers (QIBs): 213.08 times subscription
IPO Price Band: ₹563–593 per share
Grey Market Premium (GMP): ~14.67%
Listing Date: November 28, 2025
IPO Allotment Date: November 26, 2025
In the grey market, Sudeep Pharma shares are trading around ₹680, indicating a strong premium over the upper price band.
About Sudeep Pharma
Established in 1989 and based in Vadodara, Gujarat, Sudeep Pharma manufactures pharmaceutical excipients and specialty ingredients, essential components used in medicines, food, and nutrition products.
The company operates six manufacturing plants and produces mineral-based ingredients like calcium, magnesium, iron, zinc, sodium, and potassium.
Its portfolio includes more than 200 items supplied to various industries.
How IPO Funds Will Be Used
The IPO includes a fresh issue of shares.
Around ₹75.81 crore will be used to purchase new machinery for the Nandesari Facility I in Gujarat.
The remaining funds will support general corporate purposes.
How to Check IPO Allotment
Investors can track their Sudeep Pharma IPO allotment through multiple channels:
BSE Website: Go to the IPO allotment section, select Sudeep Pharma, and enter your PAN or application number.
NSE Website: Check bid details under equity offers, submit your PAN and application number, and view allotment status.
Registrar Portal (MUFG Intime): Choose Sudeep Pharma from the list and enter PAN, DP ID/Client ID, or linked bank account number.
Allotment Breakdown
QIBs: 50% of shares
NIIs: 15%
Retail Investors: 35%
Anchor Investors: 30% of institutional shares
The IPO GMP of 14% indicates potential premium listing, though the actual price may vary on the listing day.
